Scientific Advisory Board

Makarand Jawadekar, Ph.D.,

 

Makarand Jawadekar, Ph.D., is currently an independent pharma professional. He worked for Pfizer, Inc. for 28 years. In 2010 he was Director, Portfolio Management for Pfizer. During his career with Pfizer he was responsible, at various times, for external drug delivery technology assessment, created and cultivated external partnerships and alliances for drug delivery technologies, among others. He is active on the Strategic and Scientific Advisory Boards of several companies and the Task Force in Washington DC on COVID-19.

Jimmy K. Lee, MD,

 

Jimmy K. Lee, MD, is Director of Cornea and Refractive Surgery at Montefiore Medical Center and Associate Professor of Ophthalmology and Visual Sciences at Albert Einstein College of Medicine, Bronx, New York.  

Jimmy K. Lee, MD,

 

Jimmy K. Lee, MD, is Director of Cornea and Refractive Surgery at Montefiore Medical Center and Associate Professor of Ophthalmology and Visual Sciences at Albert Einstein College of Medicine, Bronx, New York.  

Karen Kingston, B.B.A.,

 

Karen Kingston, B.B.A., Principal, Activiis where she serves as Marketing and Public Relations Strategist for healthcare companies, performs executive coaching for Fortune 500 clients, technical and creative writer responsible for production of hundreds of marketing, sales and Public Relations materials in various media. 

Gerd Kobal M.D, Ph.D.,

 

Gerd Kobal M.D, Ph.D. (PhD in Physiology, PhD in Pharmacology). Expert in Sensory Research (Smell, Taste, Pain and Sensory Irritation), Developer of clinical tests for Smell and Taste deficits as well as models to measure efficacy of analgesics (opioids and non-opioids) as Professor of Pharmacology (FAU). Developer of products that could help reduce harm from smoking and Leader of Flavor Creation based on Sensomics at Altria. Inventor and former Producer of the world’s leading Smell Test 'Sniffin' Sticks'.

Andre Melendez, Ph.D.

Dr. Melendez is Professor of Nano Science, SUNY, New York.  He has developed nanoparticles with the capacity to deliver diagnostic or therapeutic cargo to sites of active proteolysis. His laboratory has defined a multitude of redox-sensitive signaling networks that contribute to aging, cancer and immunity. He has developed both molecular and biochemical methods to manipulate and monitor the intracellular environment. Much of this work has focused on how mitochondrial-derived oxidants contribute to matrix degradation, cellular migration and regulate host immune function. Dr. Melendez has been the Principal Investigator on many projects and has published numerous papers.

 

Pooya Beigi, MD, MSc, MPH

 

Pooya Beigi, MD, MSc, MPH is a Dermatologist (London, UK), Clinical Research Fellow at the University of British Columbia (Vancouver, BC, Canada) and the President/Owner of the NWM Medical Clinic (Canada). He is also the Founder/CEO of the Misdiagnosis Association and Research Institute (MARI), Mismedicine Organization and Research Institute, both in Beverley Hills, CA, USA, and Founder/CEO of Father Medical Charity (Vancouver, BC, Canada).

Dr. Beigi established “MARI” with the aim of collecting and preparing the most comprehensive databases of misdiagnosis and error in medicine cases and conducting related medical research studies in collaboration with health organizations, universities, clinics, professors and physicians from around the world.

Also, he founded Father Medical Charity with the goal of helping patients in need, especially those in underdeveloped countries. This Charity collaborates with many physicians and nurses employed in underdeveloped countries who identify patients in need and refer them to this medical charity to receive the necessary medications or facilitate treatments for them.

He is the author of several books in the medical field, including Acrodermatitis Enteropathica; A Clinician's Guide (2015), A Clinician's Guide to Mycosis Fungoides (2016), A Clinician's Guide to Pemphigus Vulgaris (2016), A Clinician's Guide to Psoriasis (2019), and A Clinician's Guide to Alopecia Areata (2017).